The promise of cardiovascular biomarkers in assessing children with cardiac disease and in predicting cardiovascular events in adults

James D. Wilkinson, Melissa Diamond, Tracie L Miller

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Cardiac and vascular biomarkers are used in the diagnosis, assessment, and prognosis of a variety of cardiovascular diseases in adults and children. For children, cardiac biomarkers are most often used to assess cardiomyopathy or congenital cardiovascular malformations or for monitoring during cardio-pulmonary bypass and pre- and post-heart transplantation. Because the risk for cardiovascular events in adulthood can be tracked from childhood, interest is high in identifying biomarkers of vascular inflammation in children that might also predict atherosclerotic events later in life. Here, we review the most common and promising biomarkers and comment on their current and potential uses in monitoring and predicting cardiovascular dysfunction.

Original languageEnglish
Pages (from-to)25-34
Number of pages10
JournalProgress in Pediatric Cardiology
Volume32
Issue number1
DOIs
StatePublished - Aug 1 2011

Fingerprint

Heart Diseases
Biomarkers
Blood Vessels
Heart Transplantation
Cardiomyopathies
Cardiovascular Diseases
Inflammation
Lung

Keywords

  • Atherosclerosis
  • Biomarkers
  • Cardiomyopathy
  • Child
  • Congenital heart disease
  • Heart failure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pediatrics, Perinatology, and Child Health

Cite this

The promise of cardiovascular biomarkers in assessing children with cardiac disease and in predicting cardiovascular events in adults. / Wilkinson, James D.; Diamond, Melissa; Miller, Tracie L.

In: Progress in Pediatric Cardiology, Vol. 32, No. 1, 01.08.2011, p. 25-34.

Research output: Contribution to journalArticle

@article{b0c8d58712b7450b9af3c86aa4bd93b3,
title = "The promise of cardiovascular biomarkers in assessing children with cardiac disease and in predicting cardiovascular events in adults",
abstract = "Cardiac and vascular biomarkers are used in the diagnosis, assessment, and prognosis of a variety of cardiovascular diseases in adults and children. For children, cardiac biomarkers are most often used to assess cardiomyopathy or congenital cardiovascular malformations or for monitoring during cardio-pulmonary bypass and pre- and post-heart transplantation. Because the risk for cardiovascular events in adulthood can be tracked from childhood, interest is high in identifying biomarkers of vascular inflammation in children that might also predict atherosclerotic events later in life. Here, we review the most common and promising biomarkers and comment on their current and potential uses in monitoring and predicting cardiovascular dysfunction.",
keywords = "Atherosclerosis, Biomarkers, Cardiomyopathy, Child, Congenital heart disease, Heart failure",
author = "Wilkinson, {James D.} and Melissa Diamond and Miller, {Tracie L}",
year = "2011",
month = "8",
day = "1",
doi = "10.1016/j.ppedcard.2011.06.006",
language = "English",
volume = "32",
pages = "25--34",
journal = "Progress in Pediatric Cardiology",
issn = "1058-9813",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - The promise of cardiovascular biomarkers in assessing children with cardiac disease and in predicting cardiovascular events in adults

AU - Wilkinson, James D.

AU - Diamond, Melissa

AU - Miller, Tracie L

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Cardiac and vascular biomarkers are used in the diagnosis, assessment, and prognosis of a variety of cardiovascular diseases in adults and children. For children, cardiac biomarkers are most often used to assess cardiomyopathy or congenital cardiovascular malformations or for monitoring during cardio-pulmonary bypass and pre- and post-heart transplantation. Because the risk for cardiovascular events in adulthood can be tracked from childhood, interest is high in identifying biomarkers of vascular inflammation in children that might also predict atherosclerotic events later in life. Here, we review the most common and promising biomarkers and comment on their current and potential uses in monitoring and predicting cardiovascular dysfunction.

AB - Cardiac and vascular biomarkers are used in the diagnosis, assessment, and prognosis of a variety of cardiovascular diseases in adults and children. For children, cardiac biomarkers are most often used to assess cardiomyopathy or congenital cardiovascular malformations or for monitoring during cardio-pulmonary bypass and pre- and post-heart transplantation. Because the risk for cardiovascular events in adulthood can be tracked from childhood, interest is high in identifying biomarkers of vascular inflammation in children that might also predict atherosclerotic events later in life. Here, we review the most common and promising biomarkers and comment on their current and potential uses in monitoring and predicting cardiovascular dysfunction.

KW - Atherosclerosis

KW - Biomarkers

KW - Cardiomyopathy

KW - Child

KW - Congenital heart disease

KW - Heart failure

UR - http://www.scopus.com/inward/record.url?scp=79961171435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961171435&partnerID=8YFLogxK

U2 - 10.1016/j.ppedcard.2011.06.006

DO - 10.1016/j.ppedcard.2011.06.006

M3 - Article

AN - SCOPUS:79961171435

VL - 32

SP - 25

EP - 34

JO - Progress in Pediatric Cardiology

JF - Progress in Pediatric Cardiology

SN - 1058-9813

IS - 1

ER -